Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Genpact (G) over the last 17 years, with Sep 2025 value amounting to $740.8 million.

  • Genpact's Cash & Equivalents fell 27.56% to $740.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $740.8 million, marking a year-over-year decrease of 27.56%. This contributed to the annual value of $648.2 million for FY2024, which is 11.06% up from last year.
  • Genpact's Cash & Equivalents amounted to $740.8 million in Q3 2025, which was up 11.69% from $663.3 million recorded in Q2 2025.
  • In the past 5 years, Genpact's Cash & Equivalents ranged from a high of $1.0 billion in Q3 2024 and a low of $460.4 million during Q2 2022.
  • Moreover, its 3-year median value for Cash & Equivalents was $583.7 million (2023), whereas its average is $654.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 43.77% in 2022, then surged by 89.03% in 2024.
  • Quarterly analysis of 5 years shows Genpact's Cash & Equivalents stood at $899.5 million in 2021, then decreased by 28.09% to $646.8 million in 2022, then dropped by 9.76% to $583.7 million in 2023, then increased by 11.06% to $648.2 million in 2024, then decreased by 27.56% to $740.8 million in 2025.
  • Its Cash & Equivalents stands at $740.8 million for Q3 2025, versus $663.3 million for Q2 2025 and $561.6 million for Q1 2025.